Drug Profile
Research programme: human beta defensin conjugates - Sci-Engi- Medco Solutions
Alternative Names: hBD-1/MMP-2 cleavable peptides; human beta defensin-1/matrix metalloproteinase-2 cleavable peptidesLatest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator Sci-Engi-Medco Solutions
- Class Peptides
- Mechanism of Action Apoptosis stimulants; Beta defensin modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Cancer in USA
- 10 Aug 2016 Early research in Cancer in USA (unspecified route)